Emory University Investigational Drug Services — Atlanta, Georgia

Emory University Investigational Drug Services is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Emory University Investigational Drug Services has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emory University Investigational Drug Services?

Emory University Investigational Drug Services has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emory University Investigational Drug Services conducted?

Emory University Investigational Drug Services has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is Emory University Investigational Drug Services accredited by Crixeo Health?

Emory University Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emory University Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.